Robert W. Siegel

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text

Pembrolizumab Versus Paclitaxel, Gastrointestinal Oncology, Medicine +7

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL

Paul J. Emmerson, Feng Wang, Yong Du et al. · Nature Medicine · 2017 · 626 citations

Metabolic Syndrome, Energy Metabolism, Biochemistry +12

Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library

Michael J. Feldhaus, Robert W. Siegel, Lee K. Opresko et al. · Nature Biotechnology · 2003 · 515 citations

Immunocytochemical Technique, Engineering, Medicine +15

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 452 citations · Full text

Molecular Evolution of Antibody Affinity for Sensitive Detection of Botulinum Neurotoxin Type A

Ali Razai, Carmen García‐Rodríguez, Jianlong Lou et al. · Journal of Molecular Biology · 2005 · 142 citations

Sensitive Detection, Allergy, Medicine +10